| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 141, 1381-1396, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
CL Jones, S Buch, M Post, L McCulloch, E Liu and AA Eddy
Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Progressive renal fibrosis is considered to be the final common pathway leading to chronic renal insufficiency. In this study, the authors examined some of the cellular and molecular mechanisms regulating the renal accumulation of extracellular matrix (ECM) proteins using rats with puromycin amino-nucleoside (PAN) nephrosis as an acute model system. Puromycin aminonucleoside rats developed reversible nephrotic syndrome accompanied by an interstitial infiltrate of monocytes. The number of interstitial fibroblasts expressing ST4 antigen did not increase. During the first 4 days, steady-state mRNA levels for all genes examined remained at or below control levels. At 1 week, nephrotic syndrome and interstitial inflammation were established, and a period of renal cell proliferation occurred, identified by increased histone mRNA levels and localized by tritiated thymine autoradiography to tubular epithelial cells and occasional interstitial cells. Transforming growth factor-beta (TGF-beta) steady-state mRNA levels were increased eightfold, but returned to control levels by 3 weeks. At week 1, there was a 10- to 20-fold increase in kidney steady-state mRNA levels for genes encoding interstitial matrix proteins collagen I and fibronectin and basement membrane collagen IV. By in situ hybridization, alpha 1(I) procollagen mRNA was localized to interstitial cells. Immunofluorescence microscopy demonstrated focal accumulation of ECM proteins in the tubulointerstitial compartment at 2 and 3 weeks, but by 6 weeks, kidney immunohistology was normal again. Steady-state mRNA levels for the matrix degrading metalloproteinase stromelysin remained at control values, whereas the levels for interstitial collagenase were normal at week 1 and increased twofold to threefold at 2 and 3 weeks. Steady-state mRNA levels for the tissue inhibitor of metalloproteinases (TIMP) increased fivefold at 1 week and returned to baseline values over the next 2 weeks. The results of this study suggest that tubulointerstitial ECM accumulation occurs in rats with acute PAN nephrosis because of the activation of genes encoding several matrix proteins and inhibition of matrix degradation mediated by TIMP. These events are reversed during the phase of recovery from nephrotic syndrome. Increased mRNA levels for TGF-beta, possibly originating from inflammatory interstitial monocytes, are likely to be one of the mediators of the molecular events observed.
This article has been cited by other articles:
 |
|
 |
|
  G. Cai, X. Zhang, Q. Hong, F. Shao, X. Shang, B. Fu, Z. Feng, H. Lin, J. Wang, S. Shi, et al. Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1861 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Erkan, P. Devarajan, and G. J. Schwartz Mitochondria Are the Major Targets in Albumin-Induced Apoptosis in Proximal Tubule Cells J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1199 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, X. Chen, Q. Hong, H. Lin, H. Zhu, Q. Liu, J. Wang, Y. Xie, X. Shang, S. Shi, et al. TIMP-1 Promotes Age-Related Renal Fibrosis Through Upregulating ICAM-1 in Human TIMP-1 Transgenic Mice J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2006; 61(11): 1130 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Grygielko, W. M. Martin, C. Tweed, P. Thornton, J. Harling, D. P. Brooks, and N. J. Laping Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase in Puromycin-Induced Nephritis J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 943 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yamate, Y. Machida, M. Ide, M. Kuwamura, T. Kotani, O. Sawamoto, and J. LaMarre Cisplatin-Induced Renal Interstitial Fibrosis in Neonatal Rats, Developing as Solitary Nephron Unit Lesions Toxicol Pathol, February 1, 2005; 33(2): 207 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. L. Zhang, W. Selbi, C. de la Motte, V. Hascall, and A. O. Phillips Bone Morphogenic Protein-7 Inhibits Monocyte-Stimulated TGF-{beta}1 Generation in Renal Proximal Tubular Epithelial Cells J. Am. Soc. Nephrol., January 1, 2005; 16(1): 79 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Watanabe, Y. Nagashio, H. Asaumi, Y. Nomiyama, M. Taguchi, M. Tashiro, Y. Kihara, H. Nakamura, and M. Otsuki Pressure activates rat pancreatic stellate cells Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1175 - G1181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, C. E. Alpers, Y. Liu, P. Carmeliet, and A. A. Eddy Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1254 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cheng and J. P. Grande Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease Experimental Biology and Medicine, December 1, 2002; 227(11): 943 - 956. [Abstract] [Full Text]
|
|
|
|
|
|
J. H. Horstrup, M. Gehrmann, B. Schneider, A. Ploger, P. Froese, T. Schirop, D. Kampf, U. Frei, R. Neumann, and K.-U. Eckardt Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1005 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yamate, K. Sato, M. Ide, M. Nakanishi, M. Kuwamura, S. Sakuma, and S. Nakatsuji Participation of Different Macrophage Populations and Myofibroblastic Cells in Chronically Developed Renal Interstitial Fibrosis after Cisplatin-induced Renal Injury in Rats Vet. Pathol., May 1, 2002; 39(3): 322 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W.-T. Shek, R. C. Benyon, F. M. Walker, P. R. McCrudden, S. L. F. Pender, E. J. Williams, P. A. Johnson, C. D. Johnson, A. C. Bateman, D. R. Fine, et al. Expression of Transforming Growth Factor-{beta}1 by Pancreatic Stellate Cells and Its Implications for Matrix Secretion and Turnover in Chronic Pancreatitis Am. J. Pathol., May 1, 2002; 160(5): 1787 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Handa, S. E. Handa, and M. K. S. Elgemark Autoradiographic analysis and regulation of angiotensin receptor subtypes AT4, AT1, and AT(1---7) in the kidney Am J Physiol Renal Physiol, November 1, 2001; 281(5): F936 - F947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. KIM, T. ODA, J. LOPEZ-GUISA, D. WING, D. R. EDWARDS, P. D. SOLOWAY, and A. A. EDDY TIMP-1 Deficiency Does Not Attenuate Interstitial Fibrosis in Obstructive Nephropathy J. Am. Soc. Nephrol., April 1, 2001; 12(4): 736 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. NAITO, M. S. RAZZAQUE, A. NAZNEEN, D. LIU, H. NIHEI, T. KOJI, and T. TAGUCHI Renal Expression of the Ets-1 Proto-oncogene during Progression of Rat Crescentic Glomerulonephritis J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2243 - 2255. [Abstract] [Full Text]
|
|
|
|
|
|
C. I.-D. L. Cruz, P. Ruiz-Torres, R. G. del Moral, M. Rodriguez-Puyol, and D. Rodriguez-Puyol Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine Am J Physiol Renal Physiol, January 1, 2000; 278(1): F122 - F129. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
